The Daily Journal (subscription) has published its annual listing of Top 100 Lawyers in California, which includes 17th-time selection for Lieff Cabraser partner Elizabeth Cabraser and 4th-time selection for Lieff Cabraser partner Richard Heimann. After reviewing hundreds of nominations, the Daily Journal honors a chosen 100 of California’s leading lawyers who are involved in “the most cutting-edge work in litigation, regulation, and corporate transactions, and who have had the greatest impact in and beyond the legal industry.”
Congratulations to Elizabeth and Richard on this prestigious and well-deserved recognition!
About Elizabeth J. Cabraser
Elizabeth Cabraser is one of the nation’s leading class action litigators, possessing unparalleled expertise in complex civil litigation. She has served as court-appointed lead, co-lead, or class counsel in scores of federal multi-district and state coordinated proceedings, and currently serves in leadership positions in several of the nation’s highest profile civil cases, including a solo leadership role in the VW “Clean Diesel” Emissions case, and co-lead positions in the GM ignition switch defect and Takata defective airbag cases, the Fiat Chrysler Jeep Dodge diesel emissions fraud litigation, the Generic Drugs Pricing antitrust litigation, and the National Prescription Opiates litigation.
About Richard Heimann
A “lawyer’s lawyer,” Richard Heimann is one of the nation’s foremost trial attorneys, with extensive experience in complex securities, investor fraud and antitrust cases, including the historic settlements of the Wells Fargo and Boeing shareholder derivative suits, granted final approval in 2020 and 2022 respectively. Heimann has tried over 30 civil jury cases over more than four decades, and has served or serves as lead counsel in securities fraud actions including those against Petrobras, Navient, Wells Fargo, Merck, Bank of America, Schwab RMBS cases, LIBOR, Merrill Lynch, IndyMac, Broadcom, Tyco, Qwest, America Online, Peregrine, McKesson, Network Associates, Informix/Illustra, FPI/Agretech, California Micro Devices, and Scorpion I and II, representing both institutional and individual investors. In the spring of 2022, Heimann served as co-lead trial counsel in San Francisco’s successful bellwether opioids trial against manufacturers, distributors and dispensers of opioid drugs.